Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Cryopette

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Cryopettesee related information
Date Initiated by FirmNovember 28, 2011
Date PostedFebruary 23, 2012
Recall Status1 Terminated 3 on February 04, 2013
Recall NumberZ-1094-2012
Recall Event ID 60824
510(K)NumberK100596 
Product Classification Labware, assisted reproduction - Product Code MQK
ProductORIGIO MIDATLANTIC DEVICES CRYOPETTE (r) Rx only Single use only CRY-PETTE-CL LOT 123456 2013-10-10 Exp. date *** MADE IN THE USA STERILE R ***Origio, Inc. 3400 Hunter's Way, Charlottesville, VA 22911 www.origio.com The Cryopette (r) is a cryopreservative storage device that is intended for use in vitrification procedures to contain and maintain human blastocyst stage embryos.
Code Information Lot numbers/Expiration: 27109A exp. 9/2011; 29909A, exp. 10/2011; 06210A, exp. 3/2012; 06210B, exp. 3/3/2012; 16210A, exp. 6/2012; 20810A, exp. 7/2012; 22410A, exp. 8/2012; 25610A, exp. 9/2012; 32010A, exp. 11/2012; 32010B, exp. 11/2012; 35510A, exp. 12/2012; 03210A, exp. 2/2012; 05411A, exp. 2/2013; 09811C, exp. 4/2013; 09811A, exp. 4/2013; 09811B, exp. 4/2013; 14611A, exp. 5/2013; 14611B, exp. 2013; 020111, exp. 8/1/13; 020111, exp. 8/8/13; 020111, exp. 8/15/13; 020111, exp. 9/5/13; 020111, exp. 9/12/13; 020111, exp. 9/26/13
FEI Number 1216677
Recalling Firm/
Manufacturer		 ORIGIO HUMAGEN PIPETS INC.
2400 Hunters Way
Charlottesville VA 22911-7930
For Additional Information ContactCindy Showalter
434-979-4000
Manufacturer Reason
for Recall		Cryopettes were rupturing during the warming process following vitrification.
FDA Determined
Cause 2		Device Design
ActionORIGIO sent a Field Safety Corrective Action letter dated November 21, 2011, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. ORIGIO feels it is important to eliminate this risk completely. As soon as we are confident that this danger of rupture has been eliminated, we will make Cryopettes available again. Please use the attached UPS call tag to return any unused Cryopettes to ORIGIO Inc. Upon receipt, we will issue a credit to your account. We sincerely apologize for the problems this issue has caused in your laboratories. For further questions please call (434) 979-4000.
Quantity in Commerce73850 Cryopettes
DistributionWorldwide Distribution - U.S. included states of AL, AR, DE, PR, NY, MA, NH, VT, IL, CT, NJ, PA, VA, WV, NV, NC, SC, GA, FL, OH, MD, MS, IN, MI, PR, WI, MN, SD, MT, MO, TX, CO, UT, AZ, CA, HI, OR, AK, WA and in countries of Turkey, Saudi Arabia, Kuwait, Jordon, So. Korea, Taiwan, Brazil, So. Africa, Oman, Kazakhstan, Honduras, Slovenia, Serbia, Poland, Czech Republic, Romania, Croatia, Ukraine, Netherlands, Bulgaria, Hungary, Russia, Lebanon, Singapore, Malaysia, Vietnam, China, Thailand, Nigeria, Japan, Spain, Greece, Canada, Denmark, France, United Kingdom, Italy, Germany, and Australia,
Total Product Life CycleTPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database510(K)s with Product Code = MQK
-
-